首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   755篇
  免费   21篇
  国内免费   19篇
耳鼻咽喉   1篇
儿科学   10篇
基础医学   107篇
临床医学   45篇
内科学   66篇
皮肤病学   8篇
神经病学   27篇
特种医学   23篇
外科学   387篇
综合类   64篇
预防医学   15篇
眼科学   18篇
药学   19篇
中国医学   3篇
肿瘤学   2篇
  2024年   4篇
  2023年   18篇
  2022年   24篇
  2021年   25篇
  2020年   24篇
  2019年   24篇
  2018年   14篇
  2017年   11篇
  2016年   24篇
  2015年   11篇
  2014年   28篇
  2013年   24篇
  2012年   17篇
  2011年   35篇
  2010年   25篇
  2009年   18篇
  2008年   33篇
  2007年   45篇
  2006年   41篇
  2005年   23篇
  2004年   25篇
  2003年   24篇
  2002年   18篇
  2001年   14篇
  2000年   29篇
  1999年   21篇
  1998年   22篇
  1997年   17篇
  1996年   22篇
  1995年   17篇
  1994年   21篇
  1993年   11篇
  1992年   27篇
  1991年   13篇
  1990年   9篇
  1989年   9篇
  1988年   12篇
  1987年   1篇
  1986年   1篇
  1985年   3篇
  1984年   3篇
  1982年   1篇
  1981年   3篇
  1980年   1篇
  1979年   1篇
  1978年   1篇
  1970年   1篇
排序方式: 共有795条查询结果,搜索用时 15 毫秒
1.
A rat model of monitoring liver allograft rejection   总被引:5,自引:0,他引:5  
Rat models are often used to study liver allograft rejection. We have established a model for rat liver allograft rejection, monitored by fine needle aspiration biopsy (FNAB), in the strain combination PVG-to-BN with a mean survival time of 37 ± 20 days. In this model, we observed acute rejection with an intense peak of lymphoid blasts and lymphocyte-dominated inflammation in the FNAB [9.1 ± 3.0 corrected increment units (CIU)], and an eventual increase in macrophages (up to 4.2 ± 4.4 CIU), together with fibrosis and parenchymal necrosis in the graft. Markers of immune activation, such as an increase in IL-2-receptor (from 1 % ± 2 % to 21 % ± 13 %) and class II (from 20 % ± 9 % to 43 % ± 13 %) expressing lymphoid cells and induction of ICAM-1 in the graft, were consistent with the overall cellular response. The FNAB correlated well with parallel graft histology. In this rat model, the atraumatic monitoring makes a close follow-up possible without having to sacrifice the experimental animals. This saves work, animals, and costs in the study of liver rejection. Received: 2 July 1996 Accepted: 28 October 1996  相似文献   
2.
试用中华眼镜蛇蛇毒消耗补体,观察其对豚鼠到SD大鼠异种心脏移植超急性排斥反应的影响。一次性给予小剂量CCV腹腔注射后可明显降低大鼠血清补体溶血活性,4-24小时后渐降至给药前1/2以下水平。CCV可明显延长异种移植心脏4 存活时间达2.5-36小时,对照组仅为25分钟;CCV与脾切除,前列腺素E1联用可进一步延长移植心的存活时间,最长1例达40小时。  相似文献   
3.
This report of the North American Pediatric Transplant Cooperative Study summarizes data contributed by 57 participating centers on 754 children with 761 transplants from 1 January 1989 to 16 February 1989. Data collection was initiated in October 1987 and follow-up of all patients is ongoing. Transplant frequency increased with age; 24% of the patients were less than 5 years, with 7% being under 2 years. Common frequent diagnoses were: aplastic/dysplastic kidneys (18%), obstructive uropathy (16%), and focal segmental glomerulosclerosis (12%). Preemptive transplant, i.e., transplantation without prior maintenance dialysis, was performed in 21% of the patients. Dialytic modalities pretransplant were peritoneal dialysis in 42% and hemodialysis in 25%. Bilateral nephrectomy was reported in 29%. Live-donor sources accounted for 42% of the transplants. Among cadaveric donors, 41% of the donors were under 11 years old. During the first post-transplant month, maintenance therapy was used similarly for live-donor and cadaver source transplants, with prednisone, cyclosporine, and azathioprine used in 93%, 83%, and 81%, respectively. Triple therapy with prednisone, cyclosporine, and azathioprine was used in 78%, 75%, and 75% of functioning cadaver source transplants at 6 months, 12 months, and 18 months as opposed to 60%, 63%, and 54% for live-donor procedures, with single-drug therapy being uncommon. Rehospitalization during months 1–5 occurred in 62% of the patients, with treatment of rejection and infection being the main causes. Additionally, 9% were hospitalized for hypertension. During months 6–12 and 12–17, 30% and 28% of the patients with functioning grafts were rehospitalized. Times to first rejection differed significantly for cadaver and live-donor transplants. The median time to the first rejection was 36 days for cadaver transplants and 156 days for live-donor transplants. Overall, 57% of treated rejections were completely reversible although the complete reversal rate decreased to 37% for four or more rejections. One hundred and fifty-two graft failures had occurred at the time of writing, with a 1-year graft survival estimate of 0.88 for live-donor and 0.71 for cadaver source transplants. In addition to donor source, recipient age is a significant prognostic factor for graft survival. Among cadaver donors, decreasing donor age is associated with a decreasing probability of graft survival. Thirty-five deaths have occurred; 16 attributed to infection and 19 to other causes. The current 1-year survival estimate is 0.94. There have been 9 malignancies.A list of all participating centers and the names of the investigators is printed on pages 552–553  相似文献   
4.
Abstract BT563, a murine anti-IL-2R MoAb, was found to be more potent than anti-Tac in inhibiting proliferation in the mixed lymphocyte reaction. Results obtained with 33 B3.1 in these experiments were similar to those with BT563. The anti-IL-2R MoAb 2A3 was shown to be a suitable agent for monitoring the effect of BT563 on peripheral blood. IL-2R-positive cells were not detected in peripheral blood samples from 1 h after the first dose until 8 days after the last dose. Plasma trough levels were measured in patients receiving 5 or 10 mg daily. The administration of BT563 to allograft recipients did not lead to clinically significant side effects.  相似文献   
5.
Acute rejection, occurring with a reported frequency of 50–70%, is still a dominating problem after liver transplantation. Medication with ursodeoxycholic acid (UDCA) has beneficial effects in different cholestatic conditions and has also been shown to reduce HLA class I antigen expression on hepatocytes in patients with PBC. Since August 1989 we have consecutively treated all patients with primary graft function with UDCA (n = 41). Patients transplanted in the first half of 1989 served as a control group (n = 8). All patients in this study were given sequential quadruple drug immunosuppression. The treatment group were given oral UDCA 10 mg/kg per day. During the first postoperative month, 17% of the UDCA-treated patients had an episode of acute rejection compared with 75% of the control patients (P < 0.01). Liver biochemistry tests 1 month postoperatively were significantly better in patients treated with UDCA. The results suggest that adjuvant treatment with UDCA reduces acute liver graft rejection.  相似文献   
6.
Sprague-Dawley rats were ovariectomized and received bilateral sham, electrolytic or kainic acid lesions of the septum. Kainic acid lesions are purported to destroy cell bodies while not appreciably damaging fibers of passage or afferent terminals. Following priming with estradiol benzoate (EB), animals received three consecutive tests of lordosis and rejection behavior. Animals also received six tests of reactivity; one prior to each EB priming regimen and one following each lordosis and rejection test. Reactivity measures included resistance to capture and magnitude and quantity of startle responses. Electrolytic and kainic acid lesions were equivalent in facilitating lordosis. Although both lesions also increased rejection frequency, kainic acid effects were transient and markedly smaller by 60–80%. Reactivity data generally demonstrated significantly higher scores for kainic acid and electrolytic lesions groups and apparently time-dependent decreases in these scores. The results suggest that rejection behavior is not necessarily correlated with either lordosis or hyperreactivity.  相似文献   
7.
《Human immunology》2022,83(3):219-224
To date, traditional pre-transplant risk factors have failed to provide accurate risk stratification in transplantation. As a result, the practice of precision medicine remains elusive, resulting in a one-size-fits-all therapeutic approach for most patients. However, recent advancements in the understanding of HLA molecules at the molecular level have revitalized interest in HLA mismatch assessment. This review discusses HLA molecular mismatch as a potential prognostic and predictive biomarker available at the time of transplantation and answers some of the common questions and critiques of this approach. We highlight the retrospective data that supports single molecule risk categorization and explore the next steps required to evaluate its potential in clinical practice.  相似文献   
8.
9.
目标 探讨环孢霉素A(CsA)联合地塞米松局部滴眼预防高危穿透角膜移植(PKP)免疫排斥反应的效果。方法 将77眼高危PKP分为CsA组(37眼);2%CsA蓖麻油溶液联合地塞米松滴眼;对照组(40眼)单独使用地塞米松滴眼。采用生存曲线进行比较。结果 术后2年,两组植片存活率分别为89%和60%,差异有显著性(P〈0.05)。结论 2%CsA蓖麻油溶液联合地塞米松溶液局部滴眼是预防高危PKP免疫排  相似文献   
10.
目的 探讨Bcl-2基因转染对心脏移植排斥反应中心肌细胞凋亡的影响。方法 采用小鼠颈部心脏移植模型 ,随机分为 3组 :对照组、移植组、Bcl-2组。分别于术后第 1、3、5、7d各取 4只移植心脏 ,原位末端标记 (TUNEL)法染色检测心肌细胞凋亡 ,以心肌细胞凋亡阳性细胞数占总心肌细胞数的百分比作为心肌细胞凋亡指数 (apoptosisindex ,AI)。用免疫组化方法观察Bcl -2的表达情况。结果 移植组心肌细胞于术后第 1d即已出现凋亡 ,第 3d明显增加 ,第 7d达高峰。Bcl-2组术后第 1d心肌细胞即表达Bcl -2 ,第 3d表达明显增加 ,第 5d达高峰 ,第 7d仍维持高峰状态。Bcl -2组各时间点心肌细胞凋亡指数明显小于对应的移植组(P <0 0 1)。结论 Bcl -2基因转染对心脏移植排斥反应中心肌细胞凋亡有显著抑制作用  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号